These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6121387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P, Bracharz H.
    Med Klin; 1980 Dec 05; 75(25):878-82. PubMed ID: 6110162
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].
    Bracharz H, Polzien P.
    MMW Munch Med Wochenschr; 1981 Jan 30; 123(5):177-80. PubMed ID: 6110188
    [Abstract] [Full Text] [Related]

  • 5. [Abnormalities of hypotonic orthostatic regulation: cardiovascular effects of dihydroergotamine, etilefrine and their combination (author's transl)].
    Gemeinhardt S, Schardt F, Polzien P.
    Dtsch Med Wochenschr; 1981 Aug 28; 106(35):1095-9. PubMed ID: 6114845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Dihydroergot plus in the long-term therapy of orthostatic hypotonic dysregulation in older patients].
    Muth HH, Jansen W.
    Fortschr Med; 1980 Oct 23; 98(40):1571-4. PubMed ID: 6109687
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the effects of etilefrin and dihydroergotamine in management of the orthostatic syndrome].
    ZFA (Stuttgart); 1979 Mar 20; 55(8):545-8. PubMed ID: 34284
    [No Abstract] [Full Text] [Related]

  • 10. [What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
    Schardt F.
    Med Welt; 1981 Feb 06; 32(6):194-8. PubMed ID: 6110159
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Dihydergot in the treatment of orthostatic dysregulation].
    Mishra BR.
    Fortschr Med; 1979 Sep 06; 97(33):1436-40. PubMed ID: 488888
    [No Abstract] [Full Text] [Related]

  • 14. [Initial results with the antihypotensive agent Thomasin (etilefrin) under ambulatory conditions (a double-blind study)].
    Bismarck M, Rust G.
    Z Arztl Fortbild (Jena); 1982 Feb 15; 76(4):153-6. PubMed ID: 6125063
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacodynamics of etilfrine pivilate in the orthostatic syndrome].
    Hengstmann JH, Brecht T, Ewers W.
    Arzneimittelforschung; 1986 May 15; 36(5):874-7. PubMed ID: 2873822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O, Berlin E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep 15; 24(9):465-7. PubMed ID: 2877953
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of dihydroergotamine and etilefrine on experimentally-induced postural hypotension in dogs.
    Yamazaki R, Tsuchida K, Otomo S.
    J Pharmacobiodyn; 1990 Sep 15; 13(9):519-24. PubMed ID: 1707454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.